Vapor Inhaler
Product Images NDC 50804-281

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Vapor Inhaler (NDC 50804-281). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Geiss, Destin & Dunn, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (198 mg Blister Pack Label)

Principal Display Panel (198 mg Blister Pack Label)
This is a drug facts label for a nasal decongestant vapor inhaler that helps relieve nasal congestion due to the common cold, hay fever, or upper respiratory allergies. The active ingredient is Levmetamfetamine at a concentration of 50mg per inhaler. The inhaler is to be used only if the perforated tube label is intact, and one should not exceed the recommended dosage. The inhaler can cause temporary burning, stinging, sneezing, or increased nasal discharge. If symptoms persist, one should contact a doctor, and the use of this inhaler is not recommended for more than seven days. One must store the inhaler at 59°-86° F (15°-30° C); it remains effective for a minimum of 3 months after the first use. The inhaler is distributed by GlaxoSmithKline in Pacires City, GA 0260, and should be kept out of reach of children. If swallowed, seek medical help or contact Poison Control.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.